Experimental Biology and Medicine 226:758-765 (2001)
© 2001 Society for Experimental Biology and Medicine
ORIGINAL ARTICLE
Cholesterol-Lowering Effects of Maitake (Grifola frondosa) Fiber, Shiitake (Lentinus edodes) Fiber, and Enokitake (Flammulina velutipes) Fiber in Rats
Michihiro Fukushima*,1,
Tetsu Ohashi*,
Yukiko Fujiwara*,
Kei Sonoyama
and
Masuo Nakano*
* Department of Bioresource Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 0808555, Japan;
Laboratory of Food Biochemistry, Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Sapporo, Hokkaido 0608589,Japan
 |
Abstract
|
|---|
The effects of mushroom fibers on serum cholesterol and hepatic low-density lipoprotein (LDL) receptor mRNA in rats were investigated. Rats were fed a cholesterol-free diet with 50 g/kg cellulose powder (CP), 50 g/kg maitake (Grifola frondosa) fiber (MAF), 50 g/kg shiitake (Lentinus edodes) fiber (SF), or 50 g/kg enokitake (Flammulina velutipes) fiber (EF) for 4 weeks. There were no significant differences in the body weight, food intake, liver weight, cecum weight, and cecum pH among the groups. Cecal acetic acid, butyric acid, and total short-chain fatty acid (SCFA) concentrations in the SF and EF groups were significantly higher than those in the other groups. The serum total cholesterol concentration in the CP group was significantly higher than that in the MAF and EF groups. The very LDL (VLDL) + intermediate-density lipoprotein (IDL) + LDL-cholesterol concentration in the CP group was significantly higher than that in the MAF, SF, and EF groups, whereas the high-density lipoprotein (HDL)-cholesterol concentration in the EF group was significantly lower than that in the other groups at the end of the 4-week feeding period. The hepatic LDL receptor mRNA level in the EF group was significantly higher than that in the CP group. The fecal cholesterol excretion in the MAF, SF, and EF groups was significantly higher than that in the CP group. The results of this study demonstrate that MAF and EF lowered the serum total cholesterol level by enhancement of fecal cholesterol excretion, and in particular, by enhancement of hepatic LDL receptor mRNA in EF group.
Key Words: rats mushroom fiber cholesterol LDL receptor mRNA
 |
Introduction
|
|---|
Serum cholesterol concentrations have been reported to be lowered by ingestion of water-soluble fibers such as pectin and oat bran (1). The hypocholesterolemic effect of plant fibers may be due to fiber-induced alterations of intestinal absorption, intestinal or pancreatic hormone secretion, lipoprotein metabolism, bile acid metabolism, or fermentation by-products and their effects on hepatic cholesterol synthesis (2). Sonoyama et al. (3) reported that the plasma cholesterol concentration was significantly lower in rats fed sugar beet fiber than in those fed fiber-free or cholestyramine diets, and this difference was due mainly to a lower high-density lipoprotein (HDL) cholesterol concentration. Short-chain fatty acids (SCFA)particularly propionate, a fermentable metabolite of soluble fibersmay be involved in lowering the serum cholesterol concentration (4).
Dietary cholesterol presumably suppresses hepatic low-density lipoprotein (LDL) receptor activity (5). The rate-limiting enzyme in endogenous sterol biosynthesis is 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, which catalyzes the synthesis of mevalonate (6). The activity of HMG-CoA reductase is also regulated by changes in the exogenous cholesterol concentration (6). Hara et al. (7) reported that SCFA suppress cholesterol synthesis in rat liver and intestine. However, they did not determine the effects of dietary fiber on the LDL receptor mRNA and HMG-CoA reductase mRNA concentrations in liver.
Some Bisodiomycotina mushrooms have the ability to lower the serum cholesterol concentration. It is reported that hiratake (Pleurotus ostreatus) lowers the serum cholesterol concentration in rats (8), and that the fruiting body of the straw mushroom (Volvariella volvacea) lowers elevated plasma cholesterol in hypercholesterolemic hamsters, whereas the mycelium does not (9). These results suggest that the fruiting body of the straw mushroom could influence hepatic cholesterol synthesis and fecal excretion of cholesterol (9). Thus, the present study was conducted in rats fed diets including maitake (Grifola frondosa) fiber (MAF), shiitake (Lentinus edodes) fiber (SF), and enokitake (Flammulina velutipes) fiber (EF) to determine their hypocholesterolemic effects. The influence of these mushroom fiber diets on serum lipids, liver lipids, hepatic enzyme activity, and hepatic mRNAs and fecal neutral sterol and bile acid excretions was examined.
 |
Materials and Methods
|
|---|
Animals and Diets.
Male F344/DuCrj rats (8 weeks old) were purchased from Charles River Japan, Inc. (Yokohama, Japan). All animals were housed individually in cages on a 12:12-hr light:dark cycle. Temperature and humidity were controlled at 23° ± 1°C and 60% ± 5%, respectively. The rats were divided into four groups of five animals each by randomization. There were no significant differences in body weights and serum total cholesterol concentrations between groups at the start of the experimental period. The composition of the experimental diet was as follows (grams per 100 g): casein, 25; corn oil, 5; fiber, 5; mineral mixture, 3.5 (AIN-76) (10); vitamin mixture, 1 (AIN-76) (10); choline chloride, 0.2; and sucrose to 100. The experimental groups were fed for 4 weeks on one of the following diets that contained 50 g/kg of MAF, SF, and EF. The compositions of MAF, SF, and EF (grams per 100 g) are shown in Table I
. Total dietary fiber, insoluble fiber, water-soluble fiber, protein, lipid, carbohydrate, moisture, and ash were determined by AOAC procedures (11). The control group consisted of rats fed 50 g/kg of cellulose. The maitake, shiitake, and enokitake were kindly provided by Mrs. S. Fujiwara (Aibetsu Town Office, Hokkaido, Japan). The rats were allowed free access to experimental diets and water for 4 weeks. Body weight and feed consumption were recorded weekly and every day, respectively. All animal procedures described conformed to the standard principles in the Guide for the Care and Use of Laboratory Animals (12).
Analytical Procedures.
Blood samples (1 ml) were collected between 0800 and 1000 hr from the jugular veins of fasting rats. The samples were taken into tubes without an anticoagulant. After the samples stood at room temperature for 2 hr, serum was prepared by centrifugation at 1,500g for 20 min. At the end of the experimental period of 4 weeks, all fecal excretion during 2 days was collected. Fecal dry weights did not differ among groups. The rats were sacrificed by ether inhalation, and the livers were quickly removed, washed with cold saline (9 g NaCl/l), blotted dry on filter paper, and weighed before freezing for storage.
Chemical Analysis.
Total cholesterol, HDL-cholesterol, and triglyceride (TG) concentrations in the serum were determined enzymatically using commercially available reagent kits (assay kits for the TDX system; Abbott Laboratory Co., Irving, TX). The very LDL (VLDL) + intermediate-density lipoprotein (IDL) + LDL-cholesterol concentration was calculated as follows: VLDL + IDL + LDL-cholesterol = total cholesterol - HDL-cholesterol.
Total lipids were extracted from liver and feces by a mixture of chloroform/methanol (2:1, v/v) (13). The neutral sterol in each total lipid obtained by saponification was acetylated (14) and analyzed by gas-liquid chromatography (GLC) using a Shimadzu 14A chromatograph (Kyoto, Japan) with a DB17 capillary column (0.25 mm x 30 m; J&W Scientific, Folsom, CA) with nitrogen as the carrier gas. Acidic sterols in feces were measured by GLC following the method of Grundy et al. (15). A part of the cecum was taken out into desalting water in a vial without exposure to air, and was suspended. The suspension of the cecum was deproteinized by perchloric acid (final concentration of 50 g/l) cooled in ice, and the supernatant was added to a NaOH solution to precipitate perchloric acid and to form sodium salts of the SCFA. Individual SCFA was measured by GLC with a glass column (2,000 x 3 mm) packed with 80- to 100-mesh chromosorb W-AW DMCS with H3PO4 (100 ml/l) as the liquid phase after adding H3PO4 by the procedure of Hara et al. (16).
Rat Liver Enzyme Preparation.
The liver was homogenized in two volumes of cold medium containing 50 mM KCl, 2 mM MgCl2, 20 mM Tris-HCl (pH 7.6), and 250 mM sucrose in a Potter-Elvehjem-type homogenizer. After homogenization with only four strokes, the mixture was centrifuged at 1,000g for 10 min, and the supernatant fraction was then centrifuged at 12,000g for 15 min. The supernatant fraction from this centrifugation was further fractionated by centrifugation at 105,000g for 60 min and the resulting pellet was called the microsomal (Ms) fraction. This Ms fraction was washed by centrifugation at 12,000g for 15 min and then at 105,000g for 60 min in the suspension medium, and was finally suspended in 150 mM KCl (pH 7.6) containing 1 mM EDTA.
Determination of HMG-CoA Reductase (EC 1.1.1.34) Activity.
The present procedure followed the method of Lippe et al. (17) with some modifications (18). A 1.5-mg sample of protein was suspended in 200 µl of a solution containing 250 mM NaCl, 50 mM potassium phosphate (pH 7.2), 10 mM EDTA, and 10 mM dithiothreitol (DTT). The sample was pre-incubated for 20 min at 37°C and the reaction was started by adding 25 µl of a solution containing 300 mM glucose-6-phosphate, 25 µl 30 mM NADP, 1 IU glucose-6-phosphate dehydrogenase (EC 1.1.1.49), and 50 µl of 0.14 mM [314-C]HMG-CoA (0.25 MBq/ml, specific activity 59,568 disintegrations/min per nmol). After a 30-min incubation at 37°C, the reaction was stopped with 0.1 ml of 2 M HCl and the sample was left for 30 min at 37°C to allow lactonization of mevalonic acid. It was then cooled in ice and centrifuged for 10 min at 3,000g. To the supernatant fraction was added 10 µl of 0.5 M mevalonolactone (carrier) and 100 mg of Na2S2O3. The final pH of the solution was 6.5. After double extraction with 2 ml of benzene, the extract was applied to a silica-gel thin-layer chromatography (TLC) plate and was developed in benzene-acetone (1:1, v/v). The silica gel of the mevalonolactone region, detected with I2 vapor, was scraped off, transferred to a scintillation vial containing Pico-aqua cocktail (Packard Instrument Co., Inc., Meriden, CT), and the radioactivity measured with a scintillation spectrometer (Packard Instrument Co. Inc., Downers Grove, IL).
Determination of Cholesterol 7
-Hydroxylase (EC 1.14.13.17) Activity.
The procedure followed is described elsewhere (19). One milligram of microsomal protein was added to a 0.1 M potassium phosphate buffer (pH 7.4), 50 mM NaF, 5 mM DTT, 1 mM EDTA, 200 g/l glycerol, and 0.15 g/l 3-([3-cholamidopropyl]-dimethylammonio)-1-propanesulfonate (CHAPS), and the mixture was incubated for 5 min at 37°C. The reaction was initiated by adding NADPH regeneration components, the final concentrations of which were 5 mM sodium isocitrate, 5 mM MgCl2, 0.5 mM NADPH, and 0.075 units of isocitrate dehydrogenase, all in a final reaction volume of 1.0 ml. The reaction mixture was incubated at 37°C for 20 min, unless otherwise indicated, in a shaking (90 strokes/min) water bath. The reaction was terminated by adding 30 µl of 200 g/l sodium cholate, and 1 µg of 7ß-hydroxycholesterol as an internal recovery standard. The final reaction was initiated by adding 44 µl of 1 g/l cholesterol oxidase (EC 1.1.3.6) in a 10 mM potassium phosphate buffer (pH 7.4) containing 1 mM DTT and 200 g/l glycerol. This reaction mixture was incubated for 10 min at 37°C, and the reaction terminated by adding 2 ml of 950 g/l ethanol. The cholesterol metabolites from this reaction mixture were extracted by adding 6 ml of petroleum ether, vortexing, incubating at 37°C for 3 min, and then centrifuging (1,200g) for 3 min. The upper ethereal layer was collected and dried at 40°C under a nitrogen gas atmosphere. Residues from the various extractions were analyzed by C-18 reverse-phase, high-performance liquid chromatography (Shimadzu 10A) using a Zorbax ODS (4.6 mm x 0.25 mm, 56 µm, MAC-MOD Analytical, Inc., Ford, PA) column equilibrated with acetonitrile-methanol (7:3, v/v). The residues were resuspended in 0.1 ml of the same solvent mixture, and 0.02 ml was injected into the column. The metabolites were eluted with the same solvent system at a flow rate of 0.8 ml/min. After 15 min, the flow rate was increased to 2.0 ml/min for 15 min. The amount of product formed was determined by monitoring the absorbance of the effluent at 240 nm and then calculating the number of nanomoles from a calibration curve.
RNA Isolation, RT-PCR, and Southern Blot Analysis.
Total RNA was isolated from the liver by the acid guanidium-phenol-choloroform method using Isogen (Nippon Gene, Tokyo, Japan) (20). mRNA encoding apo B, LDL receptor, HMG-CoA reductase, cholesterol 7
-hydroxylase, and GAPDH (used as an invariant control) was analyzed by semi-quantitative RT-PCR and subsequent Southern hybridization of the PCR products with each inner oligonucleotide probe. Total RNA samples were treated with DNase RQ1 (Promega, Madison, WI) to remove genomic DNA and were then subjected to RT-PCR by using Moloney murine leukemia virus reverse transcriptase (Gibco-BRL, Gaithersburg, MD) and EX-Taq polymerase (Takara, Tokyo, Japan) with apo B primers of oligonucleotides (upstream primer, 5'-GAAAGCATGCTGAAAACAACC-3'; downstream primer, 5'-AGGCCTGACTCGTGGAAGAA-3'), LDL receptor primers of oligonucleotides (upstream primer, 5'-ATTTTGGAGGATGAGAAGCAG-3'; downstream primer, 5'-CAGGGCGGGGAGGTGTGAGAA-3'), HMG-CoA reductase primers of oligonucleotides (upstream primer, 5'-GCGTGCAAAGACAATCCTGGAG-3'; downstream primer, 5'-GTTAGACCTTGAGAACCCAATG-3'), cholesterol 7
-hydroxylase of oligonucleotides (upstream primer, 5'-GCCGTCCAAGAAATCAAGCAGT-3'; downstream primer, 5'-TGTGGGCAGCGAGAACAAAGT-3') , and GAPDH primers of oligonucleotides (upstream primer, 5'-GCCATCAACGACCCCTTCATT-3', downstream primer, 5'-CGCCTGCTTCACCACCTTCTT-3'). The reaction mixtures for the PCRs contained 25 pmol of each primer, 1.25 U of EX-Taq polymerase, 1 X PCR buffer (Takara), and 200 µM dNTP in a 50-µl reaction volume. The expected sizes of DNA fragments amplified with these primers were 725 bp for apo B, 931 bp for the LDL receptor, 245 bp for HMG-CoA reductase, 306 bp for cholesterol 7
-hydroxylase, and 702 bp for GAPDH. Temperature cycling was as follows: first cycle, denaturation at 94°C for 3 min, annealing at 60°C for 1 min, and extension at 72°C for 2 min. Subsequent cycles were denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and extension at 72°C for 2 min. The thermal cycling was completed by terminal extension at 72°C for 10 min. In total, 25 cycles were performed for the apo B and the LDL receptor amplifications, 30 cycles for HMG-CoA reductase and cholesterol 7
-hydroxylase, and 20 cycles for GAPDH. Amplification products were electrophoresed on 2% agarose gel and transferred to a nylon membrane (Biodyne B, Pall Bio-Support, East Hills, NY). Blots were hybridized with an apo B probe of a 54-base oligonucleotide (5'-TCCTTGCTTACCAAAAAGAGCTTCCAGTGTTGGCTCAAAGCCCTTTCCTTCTAA-3'), LDL receptor probe of a 54-base oligonucleotide (5'-GTGAACTTGGGTGAGTGGGCACTGATCTGAGGGGCAGGCAGGCACATGTACTGG-3'), HMG-CoA reductase probe of a 54-base oligonucleotide (5'-GATCTGTTGTGAACCATGTGACTTCTGACAAGATGTCCTGCTGCCAATGCTGCC-3'), cholesterol 7
-hydroxylase probe of a 54-base oligonucleotide (5'-CCCGAAGGCCTGTTTAAGTGATGACTCTCAGCCGCCAAGTGACATCATCCAGTG-3'), and GAPDH probe of a 54-base oligonucleotide (5'-TGATGACCAGCTTCCCATTCTCAGCCTTGACTGTGCCGTTGAACTTGCCGTGGG-3'). The probe was 3'-tailing labeled with digoxigenin, using a DIG oligonucleotide tailing kit (Boehringer Mannheim, Germany). Prehybridization, hybridization, and detection were carried out with a DIG luminescent detection kit (Boehringer Mannheim) as recommended by the manufacturer. The relative quantity of mRNA was estimated by densitometry scanning with x-ray film.
Statistical Analysis.
Data are presented as means and standard deviations. The mean and standard deviation for serum total cholesterol, HDL-cholesterol, and VLDL + IDL + LDL-cholesterol for each time point were calculated. The significance of differences among treatment groups was determined by analysis of variance with Duncan's multiple-range test (SAS Institute, Cary, NC). Results were considered significant at P < 0.05.
 |
Results
|
|---|
There were no significant differences in the body weight gain (CP, MAF, SF, and EF: 71 ± 10, 75 ± 9, 75 ± 10, and 66 ± 7 g/4 weeks, respectively), liver weight (CP, MAF, SF, and EF: 4.0 ± 0.3, 3.9 ± 0.2, 4.0 ± 0.2, and 3.8 ± 0.2 g/100 g body weight, respectively), food intake (CP, MAF, SF, and EF: 407 ± 31, 407 ± 25, 409 ± 12, and 386 ± 40 g/4 weeks, respectively), or cecum weight (CP, MAF, SF, and EF: 1.2 ± 0.3, 1.1 ± 0.2, 1.2 ± 0.2, and 1.2 ± 0.2 g/100 g body weight, respectively) among groups.
Table II
shows the serum total cholesterol, VLDL + IDL + LDL-cholesterol, HDL-cholesterol, and TG concentrations of rats. The serum total cholesterol concentration in the CP group was significantly higher than those in the MAF and EF groups, and the VLDL + IDL + LDL-cholesterol concentration in the CP group was significantly higher than those in the MAF, SF, and EF groups at the end of the 4-week feeding period. In particular, the serum total cholesterol concentration in the EF group was the lowest among the groups and the serum VLDL + IDL + LDL-cholesterol concentrations in all treatment groups were significantly lower than that in the CP group throughout the experimental period. The HDL-cholesterol concentration in the EF group was significantly lower than that in the other groups, and there were no significant differences in the TG concentration at the end of the 4-week feeding period.
View this table:
[in this window]
[in a new window]
|
Table II. Serum Total Cholesterol, VLDL + IDL + LDL-Cholesterol, HDL-Cholesterol, and Triglyceride Concentrations in Rats Fed Mushroom Fibers for 4 Weeks
|
|
There were no significant differences in the liver cholesterol concentration (CP, MAF, SF, and EF: 2.65 ± 0.89, 3.17 ± 0.95, 2.86 ± 0.64, and 2.92 ± 0.50 µmol/g wet liver, respectively), HMG-CoA reductase (CP, MAF, SF, and EF: 0.18 ± 0.01, 0.18 ± 0.01, 0.21 ± 0.01, and 0.20 ± 0.02 pmol/min per 1 mg protein, respectively), or cholesterol 7
-hydroxylase (CP, MAF, SF, and EF: 29.5 ± 4.0, 30.8 ± 4.8, 25.6 ± 11.4, and 29.9 ± 11.4 nmol/hr per 1 mg protein, respectively) activities among the groups.
The relative quantities of mRNAs were determined by Southern hybridization of PCR-amplified HMG-CoA reductase cDNA (Fig. 1
), cholesterol 7
-hydroxylase cDNA (Fig. 1
), apo B cDNA (Fig. 2
), and LDL receptor cDNA (Fig. 2
) in the rat liver. The values of HMG-CoA reductase, cholesterol 7
-hydroxylase, apo B, and LDL receptor mRNAs were normalized to the value of GAPDH mRNA. The values of the mushroom fiber-fed rats were expressed relative to the average values of the CP diet group, which were normalized to 100. The relative quantities of hepatic HMG-CoA reductase mRNA, hepatic cholesterol 7
-hydroxylase mRNA, and hepatic apolipoprotein B mRNA were unaffected by the diets (Figs. 1 and 2
). The relative quantity of hepatic LDL receptor mRNA in the EF group was significantly higher than that in the CP group (P < 0.05). The relative quantity of hepatic LDL receptor mRNA in the MAF group also tended to be higher than that in the CP group. However, there was no correlation between hepatic LDL receptor mRNA and serum VLDL + IDL + LDL-cholesterol (r = -0.445, 0.05 < P < 0.1).

View larger version (37K):
[in this window]
[in a new window]
|
Figure 2. Hepatic apo B mRNA and LDL receptor mRNA concentrations in rats fed mushroom fibers for 4 weeks. Each value represents the mean ± standard deviations for data obtained from five animals. Means values were significantly different (P < 0.05), as determined by analysis of variance with Duncan's multiple-range test. The value of apo B and LDL receptor mRNA was normalized to the value of GAPDH, and values for the rats fed the MAF, SF, and EF diets are expressed relative to the average values for rats fed the CP diet, which was set to 100. Inset illustrates the representative Southern hybridization of PCR amplified apo B cDNA and LDL receptor cDNA of hepatic RNA. CP, cellulose powder; MAF, maitake fiber; SF, shiitake fiber; EF, enokitake fiber.
|
|
Table III
shows the neutral steroid and acidic steroid concentrations in the feces of rats. There were no significant differences in the fecal total bile acid content among the groups. The fecal cholesterol concentrations in the MAF, SF, and EF groups were significantly higher than that in the CP group.
The SCFA level and pH in the cecum at the end of the experimental period are shown in Table IV
. Acetic acid, butyric acid, and total SCFA concentrations in the SF and EF groups were significantly higher than those in the other groups. The propionic acid concentration in the SF group was significantly higher than in the CP group. There was no significant difference in the cecal pH among groups.
 |
Discussion
|
|---|
In the present study we examined the effects of mushroom fibers on serum cholesterol, hepatic LDL receptor mRNA levels, and fecal cholesterol excretion in rats. The serum total cholesterol concentrations in the MAF and EF groups were reduced by 11% to 25% compared with the CP group. Total cholesterol concentrations were reduced in both treatment groups due to lowering of VLDL + IDL + LDL cholesterol, and also to lowering of the HDL cholesterol concentration in the EF group. Sonoyama et al. (3). reported that sugar beet fiber reduces ileal concentrations of apo A-I and apo A-IV mRNA in rats. It may be speculated that the effect of EF is due to its lowering action on ileal concentrations of apo A-I and apo A-IV mRNA or its enhancing action on HDL receptor activity in adrenals/gonads. In the present study there were no significant differences in the hepatic concentration of apo B mRNA among the groups. On the other hand, the LDL receptor mRNA level in the EF group was significantly higher than in the CP group and, in the MAF group, it also tended to be higher than in the CP group. One of the reasons for the lower serum VLDL + IDL + LDL-cholesterol concentration in the EF group may have been elevation of the LDL receptor level. We previously reported (21) that the hepatic LDL receptor mRNA level in rats fed a mushroom (Agaricus bisporus) fiber was significantly higher than that in rats fed cellulose, and the hepatic LDL receptor mRNA level correlated negatively with the serum VLDL + IDL + LDL cholesterol concentration. In the present experiment we used a cholesterol-free diet to eliminate the influence of exogenous cholesterol. The elevation of the hepatic LDL receptor mRNA level observed in rats fed EF is of particular interest.
There were no significant differences in the liver cholesterol concentration, HMG-CoA reductase activity, and HMG-CoA reductase mRNA level among the groups. Hara et al. (22) reported that products of fermentation of sugar beet fiber by cecal bacteria lower the plasma cholesterol concentration in rats and that SCFA, as a fermentation product, suppresses cholesterol synthesis in the rat liver and intestine (7). On the other hand, it has been reported that dietary fiber and the SCFA production elevate hepatic cholesterol synthesis (2326). Although the SCFA concentration was elevated in the cecum in rats fed EF in this study, no effect of elevated SCFA on cholesterol synthesis in the rat liver was demonstrated. Illman and Topping (27) reported that raising the cecal propionate concentration stimulates hepatic cholesterol synthesis through increasing fecal steroid excretion. Illman et al. (28) also reported that cecal propionate correlates negatively with the plasma cholesterol concentration and positively with cecal neutral steroids and bile acids. In our study, there was no correlation between cecal SCFA and serum total cholesterol or fecal bile acid (r = -0.406, 0.05 < P < 0.1; r = -0.184, P > 0.1, respectively). However, the cecal SCFA correlated positively with fecal cholesterol (r = 0.643, P <0.01). Kubo and Nanba (29) reported that the antihyperlipemic activities of maitake were due to the acceleration of cholesterol and bile acid excretion, and of cholesterol conversion into bile acid. On the other hand, Cheung (9) reported that straw mushroom diet lowered the plasma and hepatic cholesterol levels and increased fecal neutral sterol excretion in hamsters. We also observed that fecal cholesterol excretion in the MAF, SF, and EF groups agreed with the above report. However, we did not observe significant differences in the fecal total bile acid excretion among the groups. Thus, the lowered cholesterol concentrations in the MAF and EF groups resulted from enhanced fecal cholesterol excretion.
The ratio of primary/secondary bile acids was much higher in the CP group, suggesting lower metabolic conversion compared with the treatment groups (Table III
). Buhman et al. (30) have reported that feeding psyllium to rats enhances fecal bile acid and total steroid excretion, as well as cholesterol 7
-hydroxylase activity and cholesterol 7
-hydroxylase mRNA levels. In contrast, mushroom fibers did not accelerate cholesterol conversion to bile acid, cholesterol 7
-hydroxylase activity, or the level of cholesterol 7
-hydroxylase mRNA.
The basis for elevated fecal cholesterol was unclear in the present experiment. However, the ratio of sterols/total bile acids was very high in the SF group and tended to increase in the MAF and EF groups as compared with the CP group (Table III
). The amounts of insoluble and soluble fibers and differences in transit times in the intestine may have contributed to the observations.
In conclusion, the serum cholesterol-lowering effects in rats of the mushroom fibers were evident compared with rats fed cellulose. The fibers elevated the hepatic LDL receptor mRNA level in the EF group, reduced the HDL-cholesterol concentration in the EF group, and enhanced the fecal cholesterol excretion in the MAF and EF groups. The results demonstrate that ingestion of MAF and EF attenuates increases in the serum total cholesterol and VLDL + IDL + LDL-cholesterol concentrations in test rats.
 |
Footnotes
|
|---|
1 To whom requests for reprints should be addressed at Department of Bioresource Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 0808555, Japan. E-mail: fukushim{at}obihiro.ac.jp 
 |
References
|
|---|
-
Nishina PM, Freedland RA. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr 120:668673, 1990.
-
Kay RM. Dietary fiber. J Lipid Res 23:221242, 1982.[Abstract]
-
Sonoyama K, Nishikawa H, Kiriyama S, Niki R. Apolipoprotein mRNA in liver and intestine of rats is affected by dietary beet fiber or cholestyramine. J Nutr 125:1319, 1995.
-
Chen WJ, Anderson JW. Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med 175:215218, 1984.[Medline]
-
Ma PT, Gil G, Südhof T, Bilheimer DW, Goldstein JL, Brown MS. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci U S A 83:83708374, 1986.[Abstract/Free Full Text]
-
Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 343:425430, 1990.[Medline]
-
Hara H, Haga S, Aoyama Y, Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr 129:942948, 1999.[Abstract/Free Full Text]
-
Bobek P, Ozdin L, Kuniak L. Effect of oyster mushroom (Pleurotus ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat. Nahrung 40:222224, 1996.[Medline]
-
Cheung PCK. Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. J Nutr 128:15121516, 1998.[Abstract/Free Full Text]
-
American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 107:13401348, 1977.
-
Helrisk K. Association of Official Analytical Chemists Official Methods of Analysis, 15th ed. Arlington, VA: Association of Official Analytical Chemists, 1990.
-
National Research Council. National Research Council Guide for the Care and Use of Laboratory Animals. National Institutes of Health Publication no. 85-23, revised ed. Washington, DC: National Academy of Sciences, 1985.
-
Folch J, Lees M, Sloane-Stanley JH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497509, 1957.[Free Full Text]
-
Matsubara Y, Sawabe A, Iizuka Y. Structures of new linoroid glycosides in lemon (Citrus limon Burm. f.) peelings. Agric Biol Chem 54:11431148, 1990.
-
Grundy SM, Ahrens EH Jr, Miettinen TA. Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 6:397410 1965.[Abstract]
-
Hara H, Saito Y, Nakashima H, Kiriyama S. Evaluation of fermentability of acid-treated maize husk by rat caecal bacteria in vivo and in vitro. Br J Nutr 71:719729, 1994.[Medline]
-
Lippe G, Deana R, Cavallini L, Galzigna L. Inhibition of rat liver hydromethylglutaryl-CoA reductase by sulfhydryl reagents, coenzyme A esters synthetic compounds. Biochem Pharmacol 34:32933297, 1985.[Medline]
-
Yu-Ito R, Oba K, Uritani I. Some problems in the assay method of HMG-CoA reductase activity in sweet potato in the presence of other HMG-CoA utilizing enzymes. Agric Biol Chem 46:20872091, 1982.
-
Fukushima M, Nakano M. Effects of the lipid-saccharide complex and unsaponifiable matter from sunflowers on liver lipid metabolism and intestinal flora in rats. Biosci Biotechnol Biochem 59:860863, 1995.[Medline]
-
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156159, 1987.[Medline]
-
Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K. Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. J Nutr 130:21512156, 2000.[Abstract/Free Full Text]
-
Hara H, Haga S, Kasai T, Kiriyama S. Fermentation products of sugar-beet fiber by cecal bacteria lower plasma cholesterol concentration in rats. J Nutr 128:688693, 1998.[Abstract/Free Full Text]
-
Levrat MA, Favier ML, Moundras C, Rémésy C, Demigné C, Morand C. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr 124:531538, 1994.
-
Moundras C, Behr SR, Demigné C, Mazur A, Rémésy C. Fermentable polysaccharides that enhance fecal bile acid excretion lower plasma cholesterol and apolipoprotein E-rich HDL in rats. J Nutr 124:21792188, 1994.
-
Stark AH, Madar Z. In vitro production of short-chain fatty acids by bacterial fermentation of dietary fiber compared with effects of those fibers on hepatic sterol synthesis in rats. J Nutr 123:21662173, 1993.
-
Younes H, Levrat MA, Demigné C, Rémésy C. Resistant starch is more effective than cholestyramine as a lipid-lowering agent in the rat. Lipids 30:847853, 1995.[Medline]
-
Illman RJ, Topping DL. Effects of dietary oat bran on faecal steroid excretion, plasma volatile fatty acids and lipid synthesis in the rat. Nutr Res 5:839846, 1985.
-
Illman RJ, Storer GB, Topping DL. White wheat flour lowers plasma cholesterol and increases cecal steroids relative to whole wheat flour, wheat bran and wheat pollard in rats. J Nutr 123:10941100, 1993.
-
Kubo K, Nanba H. Anti-hyperliposis effect of maitake fruit body (Grifola frondosa). Biol Pharm Bull 20:781785, 1997.[Medline]
-
Buhman KK, Furumoto EJ, Donkin SS, Story JA. Dietary psyllium increases fecal bile acid excretion, total steroid excretion and bile acid biosynthesis in rats. J Nutr 128:11991203, 1998.[Abstract/Free Full Text]
Received for publication November 10, 2000.
Accepted for publication March 14, 2001.
This article has been cited by other articles:

|
 |

|
 |
 
T. C. Rideout, Z. Yuan, M. Bakovic, Q. Liu, R.-K. Li, Y. Mine, and M. Z. Fan
Guar Gum Consumption Increases Hepatic Nuclear SREBP2 and LDL Receptor Expression in Pigs Fed an Atherogenic Diet
J. Nutr.,
March 1, 2007;
137(3):
568 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nieminen, M. Kirsi, and A.-M. Mustonen
Suspected Myotoxicity of Edible Wild Mushrooms
Experimental Biology and Medicine,
February 1, 2006;
231(2):
221 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|